×

Head and Neck, and Endocrine Pathology: Potpourri of Non-Neoplastic Lesions and Neoplasms



Evaluated by: David B. Kaminsky, M.D., FIAC, July 29, 2017
Original release date: July 29, 2017
Access to this course expires on: December 17, 2019
CME/SAMs 11.75

Course Description
In his preface to the third edition of Atlas of Head and Neck Pathology (Elsevier, 2016), Dr. Bruce Wenig describes the updated, comprehensive survey of head and neck pathology contained within its pages, and remarks “relative to compiling a book such as this one, the advances in molecular pathology are akin to a moving target with near weekly publications that provide new information and/or information that renders previous knowledge relative to a given disease essentially moot.”

The way we learn has changed. Textbooks and journals are now supplemented by interactive processes that transfer current information expediently. Delivery of new information, curated by experts, on demand, in real time, digitally by mobile devices or social media makes constant updates available. Interactive Microscopy at the unique USCAP Interactive Learning Center provides the opportunity for personalized education in an intimate mentoring environment, simulating clinical sign-out. This course, organized by Dr. Wenig, uniting experts in head and neck / endocrine pathology, will transform your approach to selected lesions and fill practice/knowledge gaps. Think of it as a professional holiday gift to your learning curve!

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Discuss and show the morphology of the new/updated classification for keratinizing epithelial dysplasias
  • Describe features shared by salivary gland neoplasms and detail the utility of immunohistochemistry and/or molecular analysis in the diagnosis and differential diagnosis
  • Detail key diagnostic findings across a spectrum of head and neck lesions

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 11.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 11.75 SAM credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Bruce M. Wenig, M.D., Rebecca Chernock, M.D., Elham Khanafshar, M.D., Ilan Weinreb, M.D. 

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.


To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.